Patient Resources

Infusion services include outpatient IV antibiotic therapy and biologic infusion services.

Therapies include, but are not limited to the following:

 

ACTEMRA (tocilizumab)

Visit Site

BENLYSTA (belimumab)

Visit Site

CIMZIA (certolizumab)

Visit Site

ENTYVIO (vedolizumab)

Visit Site

GAMMAGARD (IVIG)

Visit Site

KRYSTEXXA (pegloticase)

Visit Site

OCREVUS (ocrelizumab)

Visit Site

ORENCIA (abatacept)

Visit Site

PROLIA (denosumab)

Visit Site

REMICADE (infliximab)

Visit Site

RITUXAN (rituximab)

Visit Site

SIMPONI ARIA (golimumab)

Visit Site

SOLU-MEDROL (methylprednisolone)

Visit Site

STELARA (ustekinumab)

Visit Site

TYSABRI (natalizumab)

Visit Site